Exercise or conversion by Karin Walker of 5000 shares of Prothena Plc subject to Rule 16b-3
PRTA Stock | USD 16.01 4.06 33.97% |
About 58% of all Prothena Plc's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Prothena plc suggests that some traders are interested. The current market sentiment, together with Prothena Plc's historical and current headlines, can help investors time the market. In addition, many technical investors use Prothena plc stock news signals to limit their universe of possible portfolio assets.
Prothena |
Filed transaction by Prothena Corp Public Ltd officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Prothena Plc's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Prothena Plc's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Prothena Plc Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Prothena Plc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Prothena Plc Fundamental Analysis
We analyze Prothena Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prothena Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prothena Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Prothena Plc is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Prothena plc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prothena Plc stock to make a market-neutral strategy. Peer analysis of Prothena Plc could also be used in its relative valuation, which is a method of valuing Prothena Plc by comparing valuation metrics with similar companies.
Peers
Prothena Plc Related Equities
ONCY | Oncolytics Biotech | 20.27 | ||||
SCPH | Scpharmaceuticals | 5.41 | ||||
MDGL | Madrigal Pharmaceuticals | 4.25 | ||||
VRDN | Viridian Therapeutics | 4.13 | ||||
STOK | Stoke Therapeutics | 2.30 | ||||
KNSA | Kiniksa Pharmaceuticals | 1.89 | ||||
NUVL | Nuvalent | 1.36 | ||||
MCRB | Seres Therapeutics | 1.36 | ||||
PCVX | Vaxcyte | 0.88 | ||||
IMCR | Immunocore Holdings | 0.57 | ||||
ACLX | Arcellx | 0.56 | ||||
CGEM | Cullinan Oncology | 0.00 | ||||
VTYX | Ventyx Biosciences | 0.87 | ||||
PLRX | Pliant Therapeutics | 0.90 | ||||
MIST | Milestone Pharmaceuticals | 6.59 | ||||
ETNB | 89bio | 7.62 |
Complementary Tools for Prothena Stock analysis
When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |